{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:11:18Z","timestamp":1776193878582,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02382-8","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T09:04:34Z","timestamp":1660295074000},"page":"447-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of rs4711998 of IL-17A, rs2275913 of IL-17A and rs763780 IL-17F gene polymorphisms with non-segmental vitiligo in a Mexican population"],"prefix":"10.1007","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7562-3961","authenticated-orcid":false,"given":"Natalia Aranza","family":"Zapata-Salazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-7918","authenticated-orcid":false,"given":"David Emmanuel","family":"Kubelis-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-5787","authenticated-orcid":false,"given":"Mauricio Andres","family":"Salinas-Santander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3444-9565","authenticated-orcid":false,"given":"Celia Nohemi","family":"Sanchez-Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-7635","authenticated-orcid":false,"given":"Ana Cecilia","family":"Xolalpa-Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-723X","authenticated-orcid":false,"given":"Marely Eugenia","family":"Gomez-Galindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0213-0031","authenticated-orcid":false,"given":"Jorge","family":"Ocampo-Candiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"issue":"4","key":"2382_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3892\/etm.2021.9743","volume":"21","author":"SL Said-Fernandez","year":"2021","unstructured":"Said-Fernandez SL et al (2021) Novel immunological and genetic factors associated with vitiligo: a review. Exp Ther Med 21(4):312","journal-title":"Exp Ther Med"},{"issue":"3","key":"2382_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan A et al (2011) Vitiligo: a comprehensive overview: Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 65(3):473\u2013491","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2382_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","volume":"54","author":"K Boniface","year":"2018","unstructured":"Boniface K et al (2018) Vitiligo: Focus on clinical aspects, immunopathogenesis, and therapy. Clin Rev Allergy Immunol 54(1):52\u201367","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"2382_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/ijd.14055","volume":"57","author":"AM Dahir","year":"2018","unstructured":"Dahir AM, Thomsen SF (2018) Comorbidities in vitiligo: comprehensive review. Int J Dermatol 57(10):1157\u20131164","journal-title":"Int J Dermatol"},{"issue":"5","key":"2382_CR5","first-page":"629","volume":"20","author":"P Kang","year":"2022","unstructured":"Kang P et al (2022) Association between vitiligo and relevant components of metabolic syndrome: a systematic review and meta-analysis. J Dtsch Dermatol Ges 20(5):629\u2013641","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"2382_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jdermsci.2015.06.011","volume":"80","author":"A Batalla","year":"2015","unstructured":"Batalla A et al (2015) Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort. J Dermatol Sci 80(2):111\u2013115","journal-title":"J Dermatol Sci"},{"issue":"4","key":"2382_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.autrev.2016.01.004","volume":"15","author":"RK Singh","year":"2016","unstructured":"Singh RK et al (2016) The role of IL-17 in vitiligo: a review. Autoimmun Rev 15(4):397\u2013404","journal-title":"Autoimmun Rev"},{"issue":"6","key":"2382_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/08820139.2020.1786397","volume":"50","author":"M Shao","year":"2021","unstructured":"Shao M et al (2021) Interleukin-17 gene polymorphism (Rs2275913 G\/A, Rs763780 C\/T) in rheumatoid arthritis: meta-analysis based on ethnicity. Immunol Invest 50(6):685\u2013699","journal-title":"Immunol Invest"},{"issue":"1","key":"2382_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","volume":"133","author":"DA Martin","year":"2013","unstructured":"Martin DA et al (2013) The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol 133(1):17\u201326","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2382_CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1016-8478(23)13153-0","volume":"19","author":"SY Hwang","year":"2005","unstructured":"Hwang SY, Kim HY (2005) Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells 19(2):180\u2013184","journal-title":"Mol Cells"},{"issue":"9","key":"2382_CR11","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10067-011-1737-y","volume":"30","author":"SA Metawi","year":"2011","unstructured":"Metawi SA et al (2011) Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol 30(9):1201\u20131207","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2382_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/135245859900500206","volume":"5","author":"D Matusevicius","year":"1999","unstructured":"Matusevicius D et al (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5(2):101\u2013104","journal-title":"Mult Scler"},{"issue":"12","key":"2382_CR13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.autrev.2014.08.022","volume":"13","author":"A Alunno","year":"2014","unstructured":"Alunno A et al (2014) Unmasking the pathogenic role of IL-17 axis in primary Sj\u00f6gren\u2019s syndrome: a new era for therapeutic targeting? Autoimmun Rev 13(12):1167\u20131173","journal-title":"Autoimmun Rev"},{"issue":"2","key":"2382_CR14","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1111\/ajd.13233","volume":"61","author":"P Acharya","year":"2020","unstructured":"Acharya P, Mathur M (2020) Interleukin-17 level in patients with vitiligo: a systematic review and meta-analysis. Australas J Dermatol 61(2):e208\u2013e212","journal-title":"Australas J Dermatol"},{"issue":"12","key":"2382_CR15","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1038\/jid.2013.237","volume":"133","author":"CQF Wang","year":"2013","unstructured":"Wang CQF et al (2013) IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J Invest Dermatol 133(12):2741\u20132752","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2382_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","volume":"36","author":"DA Bassiouny","year":"2011","unstructured":"Bassiouny DA, Shaker O (2011) Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol 36(3):292\u2013297","journal-title":"Clin Exp Dermatol"},{"key":"2382_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cyto.2016.12.014","volume":"91","author":"S Bhardwaj","year":"2017","unstructured":"Bhardwaj S et al (2017) Increased systemic and epidermal levels of IL-17A and IL-1\u03b2 promotes progression of non-segmental vitiligo. Cytokine 91:153\u2013161","journal-title":"Cytokine"},{"issue":"5","key":"2382_CR18","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/bjd.14703","volume":"175","author":"R Speeckaert","year":"2016","unstructured":"Speeckaert R et al (2016) The many faces of interleukin-17 in inflammatory skin diseases. Br J Dermatol 175(5):892\u2013901","journal-title":"Br J Dermatol"},{"issue":"2","key":"2382_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00403-019-01996-9","volume":"312","author":"N Gholijani","year":"2020","unstructured":"Gholijani N, Yazdani MR, Dastgheib L (2020) Predominant role of innate pro-inflammatory cytokines in vitiligo disease. Arch Dermatol Res 312(2):123\u2013131","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"2382_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","volume":"21","author":"JK Kolls","year":"2004","unstructured":"Kolls JK, Lind\u00e9n A (2004) Interleukin-17 family members and inflammation. Immunity 21(4):467\u2013476","journal-title":"Immunity"},{"issue":"2","key":"2382_CR21","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.jisp.2016.10.023","volume":"18","author":"IC Le Poole","year":"2017","unstructured":"Le Poole IC, Mehrotra S (2017) Replenishing regulatory T cells to halt depigmentation in vitiligo. J Investig Dermatol Symp Proc 18(2):S38\u2013S45","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"2382_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ijd.15669","volume":"61","author":"M Alhelf","year":"2022","unstructured":"Alhelf M et al (2022) Association between long noncoding RNA taurine-upregulated gene 1 and microRNA-377 in vitiligo. Int J Dermatol 61(2):199\u2013207","journal-title":"Int J Dermatol"},{"issue":"2","key":"2382_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/pcmr.12667","volume":"31","author":"M Abdallah","year":"2018","unstructured":"Abdallah M et al (2018) CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: a multicenter cross-sectional study. Pigment Cell Melanoma Res 31(2):330\u2013336","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"2382_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5114\/ada.2022.113612","volume":"39","author":"KA Tomaszewska","year":"2022","unstructured":"Tomaszewska KA et al (2022) Increased serum levels of interleukin-17 in patients with alopecia areata and non-segmental vitiligo. Postepy Dermatol Alergol 39(1):195\u2013199","journal-title":"Postepy Dermatol Alergol"},{"issue":"2","key":"2382_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1755-148X.2011.00945.x","volume":"25","author":"Y Kotobuki","year":"2012","unstructured":"Kotobuki Y et al (2012) Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris. Pigment Cell Melanoma Res 25(2):219\u2013230","journal-title":"Pigment Cell Melanoma Res"},{"issue":"4","key":"2382_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018907","volume":"6","author":"CQ Wang","year":"2011","unstructured":"Wang CQ et al (2011) Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS ONE 6(4):e18907","journal-title":"PLoS ONE"},{"issue":"2","key":"2382_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jaad.2008.09.048","volume":"60","author":"PY Basak","year":"2009","unstructured":"Basak PY et al (2009) The role of helper and regulatory T cells in the pathogenesis of vitiligo. J Am Acad Dermatol 60(2):256\u2013260","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2382_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/jocd.12517","volume":"18","author":"S Sushama","year":"2019","unstructured":"Sushama S et al (2019) Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-\u03b1) in vitiligo\u2014new insight into pathogenesis of disease. J Cosmet Dermatol 18(1):337\u2013341","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"2382_CR29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/ijd.14695","volume":"59","author":"N Bernardini","year":"2020","unstructured":"Bernardini N et al (2020) IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art. Int J Dermatol 59(4):406\u2013411","journal-title":"Int J Dermatol"},{"issue":"5","key":"2382_CR30","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1080\/13685538.2020.1806814","volume":"23","author":"E Karag\u00fcn","year":"2020","unstructured":"Karag\u00fcn E, Baysak S (2020) Levels of TNF-\u03b1, IL-6, IL-17, IL-37 cytokines in patients with active vitiligo. Aging Male 23(5):1487\u20131492","journal-title":"Aging Male"},{"issue":"3","key":"2382_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019558","volume":"27","author":"CK Sharma","year":"2017","unstructured":"Sharma CK, Sharma M, Prasad K (2017) Involvement of different genes expressions during immunological and inflammatory responses in vitiligo. Crit Rev Eukaryot Gene Expr 27(3):277\u2013287","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"6","key":"2382_CR32","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1159\/000505544","volume":"236","author":"KS Rajendiran","year":"2020","unstructured":"Rajendiran KS et al (2020) Association analysis of tumor necrosis factor alpha promoter polymorphisms and vitiligo susceptibility in South Indian Tamils. Dermatology 236(6):554\u2013564","journal-title":"Dermatology"},{"issue":"7","key":"2382_CR33","first-page":"1271","volume":"20","author":"LJ Yang","year":"2016","unstructured":"Yang LJ et al (2016) Correlation between Interleukin-17 gene polymorphism and gastric cancer susceptibility in Han Chinese population. Eur Rev Med Pharmacol Sci 20(7):1271\u20131282","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"20","key":"2382_CR34","doi-asserted-by":"publisher","first-page":"8775","DOI":"10.7314\/APJCP.2014.15.20.8775","volume":"15","author":"Y Chen","year":"2014","unstructured":"Chen Y et al (2014) Association between polymorphisms of interleukin-17A and interleukin-17F genes and silicosis susceptibility in Chinese Han people. Asian Pac J Cancer Prev 15(20):8775\u20138778","journal-title":"Asian Pac J Cancer Prev"},{"key":"2382_CR35","doi-asserted-by":"publisher","first-page":"780","DOI":"10.12659\/MSM.895494","volume":"22","author":"J Du","year":"2016","unstructured":"Du J et al (2016) Single-Nucleotide Polymorphisms of IL-17 Gene Are Associated with Asthma Susceptibility in an Asian Population. Med Sci Monit 22:780\u2013787","journal-title":"Med Sci Monit"},{"issue":"9","key":"2382_CR36","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00432-014-1674-7","volume":"140","author":"T Wr\u00f3bel","year":"2014","unstructured":"Wr\u00f3bel T et al (2014) IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia. J Cancer Res Clin Oncol 140(9):1551\u20131555","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"2382_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","volume":"15","author":"S Moretti","year":"2002","unstructured":"Moretti S et al (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15(2):87\u201392","journal-title":"Pigment Cell Res"},{"issue":"7","key":"2382_CR38","first-page":"849","volume":"24","author":"S Moretti","year":"2009","unstructured":"Moretti S et al (2009) Keratinocyte dysfunction in vitiligo epidermis: Cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol 24(7):849\u2013857","journal-title":"Histol Histopathol"},{"key":"2382_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fgene.2016.00003","volume":"7","author":"C Shen","year":"2016","unstructured":"Shen C et al (2016) Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci. Front Genet 7:3","journal-title":"Front Genet"},{"issue":"5","key":"2382_CR40","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/iji.12429","volume":"46","author":"KS Rajendiran","year":"2019","unstructured":"Rajendiran KS et al (2019) Association of Nod-like receptor protein-1 (rs2670660) and Toll-like receptor-4 (rs4986790) with non-segmental vitiligo: a case\u2013control study in South Indian population. Int J Immunogenet 46(5):321\u2013330","journal-title":"Int J Immunogenet"},{"issue":"3","key":"2382_CR41","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.4238\/2013.July.8.1","volume":"12","author":"F Al-Harthi","year":"2013","unstructured":"Al-Harthi F et al (2013) Tumor necrosis factor-\u03b1 and -\u03b2 genetic polymorphisms as a risk factor in Saudi patients with vitiligo. Genet Mol Res 12(3):2196\u20132204","journal-title":"Genet Mol Res"},{"issue":"5","key":"2382_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40257-013-0039-3","volume":"14","author":"CR Camara-Lemarroy","year":"2013","unstructured":"Camara-Lemarroy CR, Salas-Alanis JC (2013) The role of tumor necrosis factor-\u03b1 in the pathogenesis of vitiligo. Am J Clin Dermatol 14(5):343\u2013350","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"2382_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240221","volume":"15","author":"T Abd El-Raheem","year":"2020","unstructured":"Abd El-Raheem T et al (2020) Tumor necrosis factor (TNF)-\u03b1- 308 G\/A gene polymorphism (rs1800629) in Egyptian patients with alopecia areata and vitiligo, a laboratory and in silico analysis. PLoS ONE 15(12):e0240221","journal-title":"PLoS ONE"},{"issue":"3","key":"2382_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1684\/ejd.2013.2009","volume":"23","author":"H Al-Shobaili","year":"2013","unstructured":"Al-Shobaili H et al (2013) Interleukin-4 (-590 C>T) and interleukin-4 receptor (Q551R A>G) gene polymorphisms in Saudi patients with vitiligo. Eur J Dermatol 23(3):402\u2013404","journal-title":"Eur J Dermatol"},{"issue":"11","key":"2382_CR45","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/ijd.14508","volume":"58","author":"LA Ochoa-Ram\u00edrez","year":"2019","unstructured":"Ochoa-Ram\u00edrez LA et al (2019) Catalase but not vitamin D receptor gene polymorphisms are associated with nonsegmental vitiligo in Northwestern Mexicans. Int J Dermatol 58(11):1264\u20131269","journal-title":"Int J Dermatol"},{"key":"2382_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mgene.2016.02.001","volume":"8","author":"S Agarwal","year":"2016","unstructured":"Agarwal S et al (2016) Liver X Receptor-\u03b1 polymorphisms (rs11039155 and rs2279238) are associated with susceptibility to vitiligo. Meta Gene 8:33\u201336","journal-title":"Meta Gene"},{"issue":"3","key":"2382_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.5114\/ada.2018.76225","volume":"35","author":"KS Rajendiran","year":"2018","unstructured":"Rajendiran KS et al (2018) Association of PTPN22 gene polymorphism with non-segmental vitiligo in South Indian Tamils. Postepy Dermatol Alergol 35(3):280\u2013285","journal-title":"Postepy Dermatol Alergol"},{"issue":"11","key":"2382_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081736","volume":"8","author":"NC Laddha","year":"2013","unstructured":"Laddha NC et al (2013) Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility. PLoS ONE 8(11):e81736","journal-title":"PLoS ONE"},{"issue":"1","key":"2382_CR49","first-page":"206","volume":"49","author":"D Onan","year":"2019","unstructured":"Onan D et al (2019) The role of IFIH1 gene rs1990760 and rs2111485 single-nucleotide polymorphisms in generalized vitiligo predisposition. Turk J Med Sci 49(1):206\u2013211","journal-title":"Turk J Med Sci"},{"issue":"7","key":"2382_CR50","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1111\/jocd.13857","volume":"20","author":"HZ Zhang","year":"2021","unstructured":"Zhang HZ et al (2021) Associations of methylenetetrahydrofolate reductase gene (MTHFR) rs1801131 and rs1801133 polymorphisms with susceptibility to vitiligo: a meta-analysis. J Cosmet Dermatol 20(7):2359\u20132368","journal-title":"J Cosmet Dermatol"},{"issue":"12","key":"2382_CR51","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1111\/jdv.15016","volume":"32","author":"IA Gomes","year":"2018","unstructured":"Gomes IA et al (2018) The role of interleukins in vitiligo: a systematic review. J Eur Acad Dermatol Venereol 32(12):2097\u20132111","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2382_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154813","volume":"125","author":"I Agonia","year":"2020","unstructured":"Agonia I et al (2020) IL-17, IL-21 and IL-22 polymorphisms in rheumatoid arthritis: a systematic review and meta-analysis. Cytokine 125:154813","journal-title":"Cytokine"},{"issue":"4","key":"2382_CR53","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jaci.2005.12.1346","volume":"117","author":"M Kawaguchi","year":"2006","unstructured":"Kawaguchi M et al (2006) IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol 117(4):795\u2013801","journal-title":"J Allergy Clin Immunol"},{"key":"2382_CR54","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.intimp.2018.12.016","volume":"67","author":"JF Gao","year":"2019","unstructured":"Gao JF et al (2019) Associations of the IL-17A rs2275913 and IL-17F rs763780 polymorphisms with the risk of digestive system neoplasms: a meta-analysis. Int Immunopharmacol 67:248\u2013259","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"2382_CR55","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/08820139.2020.1775642","volume":"50","author":"H Nisar","year":"2021","unstructured":"Nisar H et al (2021) Impact of IL-17F 7488T\/C functional polymorphism on progressive rheumatoid arthritis: novel insight from the molecular dynamic simulations. Immunol Invest 50(4):416\u2013426","journal-title":"Immunol Invest"},{"issue":"1102","key":"2382_CR56","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/postgradmedj-2016-134637","volume":"93","author":"YH Lee","year":"2017","unstructured":"Lee YH, Bae SC (2017) Associations between circulating IL-17 levels and rheumatoid arthritis and between IL-17 gene polymorphisms and disease susceptibility: a meta-analysis. Postgrad Med J 93(1102):465\u2013471","journal-title":"Postgrad Med J"},{"issue":"4","key":"2382_CR57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/jir.2016.0088","volume":"37","author":"E Eskandari-Nasab","year":"2017","unstructured":"Eskandari-Nasab E, Moghadampour M, Tahmasebi A (2017) Meta-analysis of risk association between interleukin-17A and F gene polymorphisms and inflammatory diseases. J Interferon Cytokine Res 37(4):165\u2013174","journal-title":"J Interferon Cytokine Res"},{"issue":"8","key":"2382_CR58","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00011-013-0629-9","volume":"62","author":"X Zhang","year":"2013","unstructured":"Zhang X et al (2013) Genetic polymorphisms of interleukin 17A and interleukin 17F and their association with inflammatory bowel disease in a Chinese Han population. Inflamm Res 62(8):743\u2013750","journal-title":"Inflamm Res"},{"issue":"1","key":"2382_CR59","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/apa.15390","volume":"110","author":"A Holster","year":"2021","unstructured":"Holster A et al (2021) IL17F rs763780 single nucleotide polymorphism is associated with asthma after bronchiolitis in infancy. Acta Paediatr 110(1):222\u2013227","journal-title":"Acta Paediatr"},{"issue":"1","key":"2382_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/1756-185X.13737","volume":"23","author":"S Gao","year":"2020","unstructured":"Gao S et al (2020) Association of IL-17A-197G\/A and IL-17F-7488T\/C polymorphisms and osteoarthritis susceptibility: a meta-analysis. Int J Rheum Dis 23(1):37\u201346","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"2382_CR61","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00393-019-00720-2","volume":"79","author":"YH Lee","year":"2020","unstructured":"Lee YH, Song GG (2020) Association between IL-17 gene polymorphisms and circulating IL-17 levels in osteoarthritis: a meta-analysis. Z Rheumatol 79(5):482\u2013490","journal-title":"Z Rheumatol"},{"issue":"10","key":"2382_CR62","doi-asserted-by":"publisher","first-page":"18020","DOI":"10.1002\/jcb.29105","volume":"120","author":"HH Bafrani","year":"2019","unstructured":"Bafrani HH et al (2019) Association analysis of the common varieties of IL17A and IL17F genes with the risk of knee osteoarthritis. J Cell Biochem 120(10):18020\u201318030","journal-title":"J Cell Biochem"},{"issue":"11","key":"2382_CR63","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.12998\/wjcc.v8.i11.2280","volume":"8","author":"HY Yang","year":"2020","unstructured":"Yang HY et al (2020) Role of. World J Clin Cases 8(11):2280\u20132293","journal-title":"World J Clin Cases"},{"issue":"4","key":"2382_CR64","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4103\/ijmr.IJMR_1859_16","volume":"148","author":"R Kaur","year":"2018","unstructured":"Kaur R et al (2018) Association of genetic polymorphism of interleukin-17A & interleukin-17F with susceptibility of psoriasis. Indian J Med Res 148(4):422\u2013426","journal-title":"Indian J Med Res"},{"key":"2382_CR65","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bcmd.2018.12.001","volume":"75","author":"FM Tolba","year":"2019","unstructured":"Tolba FM et al (2019) Assessment of IL-17F rs763780 gene polymorphism in immune thrombocytopenia. Blood Cells Mol Dis 75:20\u201325","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"2382_CR66","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/08820139.2020.1778023","volume":"50","author":"EL de Moura","year":"2021","unstructured":"de Moura EL et al (2021) Association of Polymorphisms in Cytokine genes with susceptibility to Precancerous Lesions and Cervical Cancer: a systematic review with meta-analysis. Immunol Invest 50(5):492\u2013526","journal-title":"Immunol Invest"},{"issue":"5","key":"2382_CR67","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2217\/bmm-2016-0315","volume":"11","author":"S Yang","year":"2017","unstructured":"Yang S et al (2017) Relationship of IL-17A and IL-17F genetic variations to cervical cancer risk: a meta-analysis. Biomark Med 11(5):459\u2013471","journal-title":"Biomark Med"},{"issue":"1","key":"2382_CR68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/08916934.2015.1101071","volume":"49","author":"A Hammad","year":"2016","unstructured":"Hammad A et al (2016) Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis. Autoimmunity 49(1):31\u201340","journal-title":"Autoimmunity"},{"issue":"5","key":"2382_CR69","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1089\/gtmb.2016.0177","volume":"21","author":"W Ren","year":"2017","unstructured":"Ren W et al (2017) Polymorphisms in the IL-17 gene (rs2275913 and rs763780) are associated with Hepatitis B virus infection in the Han Chinese Population. Genet Test Mol Biomarkers 21(5):286\u2013291","journal-title":"Genet Test Mol Biomarkers"},{"key":"2382_CR70","doi-asserted-by":"publisher","first-page":"154784","DOI":"10.1016\/j.cyto.2019.154784","volume":"123","author":"SDC Gon\u00e7alves de Albuquerque","year":"2019","unstructured":"Gon\u00e7alves de Albuquerque SDC et al (2019) Study of association of the rs2275913 IL-17A single nucleotide polymorphism and susceptibility to cutaneous leishmaniasis caused by Leishmania braziliensis. Cytokine 123:154784","journal-title":"Cytokine"},{"issue":"10","key":"2382_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026229","volume":"6","author":"JL Espinoza","year":"2011","unstructured":"Espinoza JL et al (2011) A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS ONE 6(10):e26229","journal-title":"PLoS ONE"},{"issue":"10","key":"2382_CR72","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3109\/02770903.2015.1044251","volume":"52","author":"Y Jin","year":"2015","unstructured":"Jin Y et al (2015) IL-17 polymorphisms and asthma risk: a meta-analysis of 11 single nucleotide polymorphisms. J Asthma 52(10):981\u2013988","journal-title":"J Asthma"},{"issue":"3","key":"2382_CR73","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clinre.2015.10.004","volume":"40","author":"J Wang","year":"2016","unstructured":"Wang J et al (2016) Association of IL-17A and IL-17F gene polymorphisms with chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: a case\u2013control study. Clin Res Hepatol Gastroenterol 40(3):288\u2013296","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2382_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104638","volume":"87","author":"W Wu","year":"2021","unstructured":"Wu W et al (2021) IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han population. Infect Genet Evol 87:104638","journal-title":"Infect Genet Evol"},{"key":"2382_CR75","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/01.EWX.0000503399.60863.9f","volume":"14","author":"F Mohammed","year":"2017","unstructured":"Mohammed F et al (2017) Study of interleukin-17 gene polymorphism and susceptibility to vitiligo in a sample of the Egyptian population. J Egypt Women\u02bcs Dermatol Soc 14:45\u201348","journal-title":"J Egypt Women\u02bcs Dermatol Soc"},{"key":"2382_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.801724","volume":"12","author":"SD Jadeja","year":"2021","unstructured":"Jadeja SD et al (2021) Elevated X-box binding protein1 splicing and interleukin-17A expression are associated with active generalized vitiligo in Gujarat population. Front Immunol 12:801724","journal-title":"Front Immunol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02382-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T08:46:23Z","timestamp":1727772383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02382-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":76,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["2382"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02382-8","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Research involving human participants: This study was approved by the local research ethics committee of University Hospital \u2018Dr Jose Eleuterio Gonz\u00e1lez\u2019 with the registry number DE20-00003, and it was performed according to the Declaration of Helsinki (1983).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study was approved by the local research ethics committee of University Hospital \u2018Dr Jose Eleuterio Gonzalez\u2019 with the registry number DE20-00003, and it was performed according to the Declaration of Helsinki (1983).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}}]}}